CONTINEUM THERAPEUTICS, INC. CLASS A COMMON STOCK

NASDAQ: CTNM (Contineum Therapeutics, Inc.)

Last update: 05 Mar, 8:40AM

6.25

-0.34 (-5.16%)

Previous Close 6.59
Open 6.79
Volume 60,508
Avg. Volume (3M) 89,646
Market Cap 161,111,248
Price / Sales 11.15
Price / Book 0.580
52 Weeks Range
6.21 (-0%) — 22.00 (252%)
Diluted EPS (TTM) -2.49
Total Debt/Equity (MRQ) 3.25%
Current Ratio (MRQ) 21.47
Operating Cash Flow (TTM) -39.28 M
Levered Free Cash Flow (TTM) -26.34 M
Return on Assets (TTM) -22.95%
Return on Equity (TTM) -33.03%

Market Trend

Short Term Medium Term
Industry Biotechnology (US) Bearish Bearish
Biotechnology (Global) Bearish Bearish
Stock Contineum Therapeutics, Inc. Bullish Bearish

AIStockmoo Score

2.1
Analyst Consensus 5.0
Insider Activity NA
Price Volatility 0.5
Technical Moving Averages 2.5
Technical Oscillators 0.5
Average 2.13

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
CTNM 161 M - - 0.580
MTSR 3 B - - 6.12
DNTH 606 M - - 1.84
BCYC 515 M - - 0.660
MAZE 504 M - 164.29 1.82
RAPP 439 M - - 1.54

Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.

Sector Healthcare
Industry Biotechnology
% Held by Insiders 1.82%
% Held by Institutions 79.99%
52 Weeks Range
6.21 (-0%) — 22.00 (252%)
Price Target Range
20.00 (220%) — 31.00 (396%)
High 31.00 (RBC Capital, 396.00%) Buy
Median 25.50 (308.00%)
Low 20.00 (Morgan Stanley, 220.00%) Buy
Average 25.50 (308.00%)
Total 2 Buy
Avg. Price @ Call 4.16
Firm Date Target Price Call Price @ Call
Morgan Stanley 19 May 2025 20.00 (220.00%) Buy 4.37
RBC Capital 15 May 2025 31.00 (396.00%) Buy 3.94

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria